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Abstract
Currently, there are isolated data on the relationship between IL-4 polymorphism (C-589T) and susceptibility to brucello-
sis. Therefore, the purpose of the study was to determine the frequency of polymorphism of IL-4 (C-589T) in patients with acute 
brucellosis.
Materials and methods: the article presents the results of surveys of 120 patients with acute brucellosis. The control group 
consisted of 30 practically healthy persons. The diagnosis of brucellosis was based on complaints, anamnesis, epidemiological and 
clinical data, and the results of a specific study. The definition of the polymorphism of IL-4 (C-589T) was performed for all patients 
in the main and control group. A detailed description of patients with brucellosis is presented. Among the observed prevailed men 
and young people of working age.
Results: A mild degree was established in 74 (61.66 %) patients, while severe - only in 11 (9.17 %) patients. It was determined 
that the genotype CT (65.83 %) was significantly more common among patients with brucellosis than in the control group, where the 
frequency of this genotype was only 16.66 %. While the CC genotype was 3.2 times more common among healthy individuals than 
among patients in the main group (76.67 % versus 24.17 %), it was found that the CC genotype of the IL-4 gene was 13 times more 
common in patients for acute brucellosis with mild progress than with severe.
Conclusions: The genotype IL-4 (C-589T) SS is significantly associated with the mild course of brucellosis.
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1. Introduction
Brucellosis is one of the most common zoonotic infections in the world with a high per-
centage of chronic forms. This is respectively negatively affects the economic component of 
health systems in countries with high prevalence of brucellosis [1, 2]. One of the highest rates 
of brucellosis morbidity is observed in Central Asia and Eastern Europe [3, 4]. A high level of 
morbidity remains in Azerbaijan, especially in areas where livestock is actively involved. Ac-
cording to various data in the world from a few million to 500 thousand new cases of brucellosis 
is recorded annually [5, 6].
In the pathogenesis of acute brucellosis, the immunological imbalance is emerging. Cy-
tokines play one of the key roles in modulating the immune response. One of the factors that 
influence the activity of cytokines is polymorphisms, which encode protein molecules of genes of 
cytokines [7, 8].
Serum IL-4 levels are generally elevated in patients with acute brucellosis, since it is an 
anti-inflammatory cytokine that activates humoral immunity and also participates in the control 
of the proliferation and differentiation of B cells and T-helper cells. The role of the IL-4 polymor-
phism for some diseases, including Behcet’s disease [9], has been proved. Also, for the diseases of 
the pathogenesis, an important role is played by the immunoallergic component, namely, at atopic 
bronchial asthma, rheumatoid arthritis, chronic obstructive pulmonary disease, allergic rhinitis 
[10, 11]. The above data indicates the universality of the IL-4 gene, which is capable of participating 
in the inflammatory reaction of any genes, including in brucellosis.
At present there are small, conflicting data on the relationship between IL-4 polymorphism 
and brucellosis susceptibility. Yes, by Ozgur Gunal et al. in 2017, it was found that individuals with 
P1 and P2P1 polymorphisms of the genotype IL-4 VNTR are susceptible to brucellosis [12]. Then, 
as investigated by Manoochehr Rasouli et al., 2007, IL-4CC polymorphism was found to be related 
to brucellosis resistance [13].
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2. Aim of the research
Determine the frequency of polymorphism of IL-4 (C-589T) in patients with acute brucel-
losis in the Republic of Azerbaijan.
3. Materials and methods of the research
In the framework of this work 178 patients with signs of brucellosis were examined, who 
applied for medical assistance at Baku Clinic and the Central Clinical Hospital of Baku during 
2012–2017. All patients gave a permission to include them in the study.
The diagnosis of acute brucellosis was established on the basis of clinical data, anamnesis, 
including epidemiological, data of objective examination, results of specific and nonspecific labo-
ratory diagnostics.
Specific methods of the study were conducted using ELISA on Awareness and StatFax 
3200 devices using NovaLisa BrusellaI gG, IgM (Germany) test systems for detecting IgM and IgG.
Criteria for inclusion in the study were to establish the diagnosis of acute brucellosis, while 
taking into account the duration of clinical symptoms, namely, 3 months from the date of the first 
complaints, as well as the presence of specific markers of acute brucellosis.
According to the criteria for inclusion in a study of 178 patients surveyed, only 120 persons, 
who were the main group, fully met all criteria. The control group consisted of 30 practically 
healthy persons who underwent a planned annual review. The groups were representative by age 
and gender. Patients of both groups are ethnic Azerbaijani who live permanently in Azerbaijan. The 
average age of patients in the main group was 35.9±2.8 years. Among the surveyed, male subjects 
were dominated by 75.00 %.
Criteria for exclusion from the study: persons under the age of 18 years, confirmation of the 
diagnosis of subacute or chronic brucellosis, the presence of severe chronic concomitant pathology, 
which could significantly affect the reliability of the results.
Also, the definition of the polymorphism of IL-4 (C-589T) was performed for all patients in 
both groups. The amplification of the DNA of the studied loci was carried out automatically using the 
following primers: 5’AACACCTAAACTTGGGAGGA3 and 5’CTGTCATGGAAAAGCTGATCT3’. 
After initial denaturation at 94°C for 5 minutes each stage took place in 3 stages: denaturation – 
94 °C (30 s), annealing of primers (30–45 s), elongation – 72°C (30–40 s). The final elongation 
lasted 7 minutes at 72°C. The allelic isolation of IL-4 gene was used to limit the restriction of the 
amplicons using the AvaII endonuclease restriction. The products of the hydrolysis of the amplified 
sequences were analyzed by electrophoresis in a 2 % agarose gel. 
The reliability of the differences in the distribution of genotypes by polymorphic loci be-
tween the groups was verified to correspond to the Hardy-Weinberg equilibrium.
The statistical processing of the obtained results was carried out using the program “STA-
TISTICA 6.0”. Student’s parametric test was used to compare two independent samples and one-di-
mensional dispersion analysis to compare more than 2 independent samples. Values of p <0.05 were 
considered as reliable.
5. Results of the research
In the analysis of polymorphism of the IL-4 (C-589T), it was found that the genotype CT 
(65.83 %) is significantly more common among patients with brucellosis than in the control group, 
where the frequency of this genotype was only 16.66 %. Whereas, the CC genotype was 3.2 times 
more common among healthy individuals than among patients in the main group (76.67 % vs. 
24.17 %). Regarding the distribution frequency of the alleles C and T, IL-4 (C-589T), a significant 
difference was found only among healthy subjects, so the frequency of carriers of allele C was 
5.7 times higher than the allele T frequency (p <0.05) (Table 1).
Taking into account the above results and the data available that the level of IL-4 can sig-
nificantly change depending on the severity of brucellosis [14, 15], we have decided to analyze the 
frequency of detection of the polymorphism of IL-4 (C-589T) depending on the degree of severity. 
To do this, all 120 patients with acute brucellosis were divided into three subgroups of severity. The 
following symptoms were the criterion of severity: fever, sweating, chills, headache, insomnia, low 
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blood pressure, tachycardia, hepatosplenomegaly, myocarditis, pericarditis, endocarditis, changes 
in the general blood count, levels of pro-inflammatory and anti-inflammatory cytokines [16]. Thus, 
an easy degree was established in 74 (61.66 %) persons, the moderate degree was 35 (29.17 %) and 
in only 11 (9.17 %) patients the condition was severe (Fig. 1).
Table 1
Frequency of detection of polymorphism (C-589T) of the gene IL-4 in patients with acute brucellosis and 
healthy individuals
Genotypes and alleles IL-4(С-589Т)




Abs. % Abs. %
CC 29 24.17 23 76.67*
CТ 79 65.83 5 16.66*
ТТ 12 10.00 2 6.67
Allele C 137 57.08 51 85.00
Allele Т 103 42.92 9 15.00
Note: * – p<0.05 – between patients with acute brucellosis and healthy persons
Fig. 1. Distribution of patients with brucellosis depending on severity
It was found that the CC genotype of the IL-4 gene was 13 times more likely to be detected 
in patients with acute brucellosis than in severe cases (p <0,05). In other genotypes, no reliable 
differences were found (Table 2).
Table 2
Frequency of detection of polymorphism (C-589T) of IL-4 gene in patients with brucellosis 
Genotypes  
IL-4(С-589Т)
Patients with brucellosis (n=120)
Easy severity (n=74) Moderate severity (n=35) Heave severity level (n=11)
Abs. % Abs. % Abs. %
CC 28 37.84 1 2.86* 0 0
CТ 39 52.70 31 88.57 9 81.82
ТТ 7 9.46 3 8.57 2 18.18
Note: * – p<0.05 – between patients with brucellosis with different degrees of severity.
6. Discussion of the results
The role of IL-4 polymorphism and its relationship with brucellosis is ambiguous and poor-
ly understood. Currently, there are isolated data, so in one study, the polymorphism of the IFN-γ 
and IL-4 genes at positions +874 and –590, respectively, in patients with brucellosis was analyzed. 
Based on their analysis, the researchers concluded that individuals with an IFN-γAA genotype 
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is, Rasouli M. et al. 2007, it is believed that carriers of the genotype CC IL-4 are more resistant to 
brucella infection, indicating the protective effect of this genotype [13].
A group of Turkish researchers analyzed another polymorphism of the IL-4, namely, VNTR, 
concluding that carriers of the P1 allele and the P2P1 IL-4VNTR genotype are at risk for the devel-
opment of brucellosis [12].
Rezazadeh M. et al., in 2006 found that the genotype CT of the gene IL-4 (C-589T) is as-
sociated with a significantly greater risk of developing brucellosis with a correlation of chances of 
4.2 (95 % CI 2.7-6.6, p<0.0001) [17].
The data obtained by us in some ways coincide with previous studies, so that the genotype 
of CC IL-4 (C-589T) was 3.2 times more commonly registered among healthy individuals than 
among patients with brucellosis, and more often associated with the mild course of the disease [18].
Taking into account the analyzed literature data and the data we have received, we consider, 
like most researchers that the ambiguity of the results may be due to the diversity of ethnic groups 
that participated in various studies [19, 20].
7. Conclusions
1. The genotype of CC IL-4 (С-589Т) was 3.2 times more common among healthy individu-
als than among patients with brucellosis, whereas the CT genotype, on the contrary, was 3.9 times 
more frequently recorded among patients.
2. It was established that the genotype IL-4 (C-589T) CC is significantly associated with the 
mild progression of brucellosis.
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